PD‐1/PD‐L1 pathway: Basic biology and role in cancer immunotherapy
Tabriz University of Medical Sciences · Mashhad University of Medical Sciences · +4 more institutions
Abstract
Over the course of past few years, cancer immunotherapy has been accompanied with promising results. However, preliminary investigations with respect to immunotherapy concentrated mostly on targeting the immune checkpoints, nowadays, emerge as the most efficient strategy to raise beneficial antitumor immune responses. Programmed cell death protein 1 (PD-1) plays an important role in subsiding immune responses and promoting self-tolerance through suppressing the activity of T cells and promoting differentiation of regulatory T cells. PD-1 is considered as an immune checkpoint and protects against autoimmune responses through both induction of apoptosis in antigen-specific T cells and inhibiting apoptosis in…
Citation impact
- FWCI
- 23.31
- Percentile
- 100%
- References
- 129
Authors
7- ASArash Salmaninejad
Tabriz University of Medical Sciences, Mashhad University of Medical Sciences
- SFSaeed Farajzadeh Valilou
Universal Scientific Education and Research Network
- AGArezoo Gowhari Shabgah
Mashhad University of Medical Sciences
- SASaeed Aslani
Tehran University of Medical Sciences
- MAMalihe Alimardani
Mashhad University of Medical Sciences
Topics & keywords
- Immunotherapy
- Immune system
- Cancer immunotherapy
- Immune checkpoint
- Cancer research
- Monoclonal antibody
- Cancer
- Immunology
- Good health and well-being